| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/02/2001 | EP1071329A4 Methods and compositions for treatment of aids-associated kaposi's sarcoma |
| 05/02/2001 | EP0817860B1 Pseudotyped retroviral particles |
| 05/02/2001 | EP0769947B1 Indolinone compounds for the treatment of disease |
| 05/02/2001 | CN1293661A Pyridazinone hydrochloride compound and method for producing the same |
| 05/02/2001 | CN1293574A Materials for preventing arteriosclerosis, Immunopotentiating meterials, vertegrates fed with these materials and eggs thereof |
| 05/02/2001 | CN1293249A Human transmembrane glycosyl transport factor and its coding sequence |
| 05/02/2001 | CN1293248A Human shear and adenylation specific factor protein and its coding sequence |
| 05/02/2001 | CN1293247A Human zinc finger protein and its coding sequence |
| 05/02/2001 | CN1293195A New polycyclicazaindole compound, its preparation method are medicine composition containing same |
| 05/02/2001 | CN1293042A Propolis honey and its preparing process |
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225351 For therapy of asthma, arthritis, and sepsis bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, dermatitis, sepsis, septic shock, cachexia, acquire immuno deficiency syndrome (aids) |
| 05/01/2001 | US6225335 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease |
| 05/01/2001 | US6225328 Adamantyl-substituted retinoids and pharmaceutical/cosmetic compositions comprised thereof |
| 05/01/2001 | US6225300 TNF receptor and steroid hormone in a combined therapy |
| 05/01/2001 | US6225292 Inhibitors of DNA immunostimulatory sequence activity |
| 05/01/2001 | US6225289 Methods and compositions for preserving adenoviral vectors |
| 05/01/2001 | US6225288 Implicated in modulating apoptosis; treatment of:cardiac and cerebral ischemia/reperfusion injury, spinal cord injury and organ damage during transplantation, chronic neurodegenerative diseases, immunodeficiency, diabetes, alopecia, aging |
| 05/01/2001 | US6225284 Somatostatin peptides |
| 05/01/2001 | US6225117 Antibodies against human IL-12 |
| 05/01/2001 | US6225091 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory synctial virus |
| 05/01/2001 | US6225083 Nucleotide and amino acid sequences of membrane protein involved in cell division; drug screening; bactericides; bacteriostats; antibiotics; for meningitis, sinusitis, conjunctivitis, otitis media, and endocarditis |
| 05/01/2001 | US6224912 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| 05/01/2001 | US6224881 DNA molecule fragments encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 05/01/2001 | US6224879 Genetic engineering |
| 05/01/2001 | US6224870 Administering a nucleic acid |
| 05/01/2001 | US6224869 Isolated polypeptide |
| 05/01/2001 | CA2268703C Enantiomerically pure .beta.-d-dioxolane nucleosides with selective anti-hepatitis b virus activity |
| 05/01/2001 | CA2121473C Methods and compositions for treating allergic reactions |
| 04/26/2001 | WO2001029206A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029081A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 04/26/2001 | WO2001029078A2 Method for production and use of mite group 1 proteins |
| 04/26/2001 | WO2001029073A1 Methods for improving secondary metabolite production in fungi |
| 04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | WO2001029049A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 04/26/2001 | WO2001029042A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029028A1 9- (piperazinylalkyl) carbazoles as bax-modulators |
| 04/26/2001 | WO2001029027A1 2-alkoxybenzene derivatives |
| 04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 04/26/2001 | WO2001029016A1 Process for preparing piperazine-substituted aliphatic carboxylates |
| 04/26/2001 | WO2001029007A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 04/26/2001 | WO2001029000A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 04/26/2001 | WO2001028991A1 N-cycloalkyl thiooxamide derivatives |
| 04/26/2001 | WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/26/2001 | WO2001028583A2 Melanoma vaccine and methods of making and using same |
| 04/26/2001 | WO2001028581A1 Medicinal compositions for inhibiting gvhd |
| 04/26/2001 | WO2001028580A2 Modulation of angiogenesis |
| 04/26/2001 | WO2001028557A1 Cannabimimetic indole derivatives |
| 04/26/2001 | WO2001028550A1 Topical anesthetics useful for treating cancer, autoimmune diseases and ischemia |
| 04/26/2001 | WO2001028543A1 TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-δ ACTIVITY |
| 04/26/2001 | WO2001028523A1 Powder pharmaceutical formulations |
| 04/26/2001 | WO2001005970A3 Gtp-binding protein associated factors |
| 04/26/2001 | WO2001003645A3 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 04/26/2001 | WO2000077040A3 Human intracellular signaling molecules |
| 04/26/2001 | WO2000064486A3 Enzymatically activated polymeric drug conjugates |
| 04/26/2001 | WO2000063369A3 Gene therapy |
| 04/26/2001 | WO2000061121A3 Use of molecular weight-amplified hirudin as an anticoagulant in extracorporeal renal replacement therapy |
| 04/26/2001 | WO2000056889A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | WO1997035591B1 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 04/26/2001 | US20010000513 Treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation |
| 04/26/2001 | DE19951072A1 New cell constructs from activated T-cells of patients useful as a medicament |
| 04/26/2001 | DE19950898A1 New heteroaryl substituted fluoroalkyl-benzoylguanidine derivatives useful for treatment of e.g. ischemias, cardiac infarction, angina, shock, atherosclerosis, cancer and metabolic disorders |
| 04/26/2001 | DE19950647A1 Benzopyranoimidazolone and benzothiopyranoimidazolone derivatives as phosphodiesterase-VII inhibitors useful for treatment of e.g. asthma, psoriasis, osteoporosis, cachexia, sepsis, tumors and AIDS |
| 04/26/2001 | DE19949594A1 Rekombinante attenuierte Listerien zur Immuntherapie Recombinant attenuated Listeria for immunotherapy |
| 04/26/2001 | CA2389317A1 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | CA2388497A1 Method of producing differentiated progenitor cells by culturing morula or inner cell mass cells |
| 04/26/2001 | CA2388427A1 Methods for improving secondary metabolite production in fungi |
| 04/26/2001 | CA2387892A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 04/26/2001 | CA2387855A1 Melanoma vaccine and methods of making and using same |
| 04/26/2001 | CA2387786A1 Treatment of eosinophil associated pathologies by modulating pkc-.delta. activity |
| 04/26/2001 | CA2387138A1 Cannabimimetic indole derivatives |
| 04/26/2001 | CA2386922A1 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | CA2386398A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 04/26/2001 | CA2386049A1 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 04/26/2001 | CA2384537A1 Modulation of angiogenesis |
| 04/26/2001 | CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/26/2001 | CA2382978A1 Powder pharmaceutical formulations |
| 04/25/2001 | EP1094109A2 Human G protein-coupled receptor, PFI-010 |
| 04/25/2001 | EP1094075A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094063A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators |
| 04/25/2001 | EP1093822A2 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/25/2001 | EP1093821A2 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/25/2001 | EP1093820A2 Oral immunology using plant product containing hepatitis surface antigen |
| 04/25/2001 | EP1093814A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 04/25/2001 | EP1093521A2 Human transferases |
| 04/25/2001 | EP1093465A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 04/25/2001 | EP1093457A1 Cytokine receptor common gamma chain like |
| 04/25/2001 | EP1093382A2 Use of an amphipathic compound for providing an adjuvant to a subunit vaccine |
| 04/25/2001 | EP1093381A1 Antigenic peptides derived from telomerase |
| 04/25/2001 | EP1093374A1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 04/25/2001 | CN1292827A Nucleic acid transfer vectors, compositions containing same and uses |
| 04/25/2001 | CN1292797A Cholenic acid amides and pharmaceutical compositions thereof |
| 04/25/2001 | CN1292781A Antivirals |
| 04/25/2001 | CN1292700A IgE antibody production inhibitors and autoimmune diseases inhibitors |
| 04/25/2001 | CN1292686A Delivery system to modulate immune response |
| 04/25/2001 | CN1292684A Emulsion preconcentrate containing cyclosporin or macrolide |
| 04/25/2001 | CN1292420A New human NADH oxido-reductase composite I subunit and its code sequence |